|
Market Closed -
Nasdaq
16:00:00 2026-10-07 EDT
|
5-day change | 1st Jan Change | ||
| 16.42 USD | -6.17% |
|
-4.20% | - |
| 09-20 | Attovia Therapeutics, Inc.(NasdaqGM:ATTO) added to S&P TMI Index | CI |
| 09-16 | Attovia Therapeutics, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 10:00 AM |
Evolution of the Average Target: Attovia Therapeutics, Inc.
Evolution of the Target Price: Attovia Therapeutics, Inc.
Changes in Analyst Recommendations: Attovia Therapeutics, Inc.
16ddc93789.iQbqYKvD4UU7BCqvlZRYAZoLDeeavOkrIkMIfgBr4nA.5V-8OoaUliNdTFPh3NJpNcx-P9PPxJpgZAtpRm8MtybBbYkLmIK-PWgxYw~033db840e11a7f187328484d3c102f79
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +141.14% | |||
| +13.99% | |||||
| +24.38% | |||||
| +19.43% | |||||
| +29.48% | |||||
| +11.87% | |||||
| +19.5% | |||||
| +46.79% | |||||
| +0.6% | |||||
| +21.55% | |||||
| Average | +32.87% | |||||
| Weighted average by Cap. | +20.51% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
16.42USD
Average target price
42.20USD
Spread / Average Target
+157.00%
High Price Target
52.00USD
Spread / Highest target
+216.69%
Low Price Target
30.00USD
Spread / Lowest Target
+82.70%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- ATTO Stock
- Consensus Attovia Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
